The Telomere Length Signature in Leukemias—From Molecular Mechanisms Underlying Telomere Shortening to Immunotherapeutic Options Against TelomeraseStella Baliou, Eftichia Stiakaki, Miruna-Maria Apetroaei et al.|Cancers|2025Cited by 4